S. Maury

发表

PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma.

E. Itti, C. Cordonnier, D. Bories, 2006, Haematologica.

Phase 2 clinical trial of 5-azacitidine, valproic acid, and all-trans retinoic acid in patients with high-risk acute myeloid leukemia or myelodysplastic syndrome

H. Dombret, P. Böelle, S. Chevret, 2010, Oncotarget.

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis

W. Vainchenker, M. Tulliez, C. James, 2006, Leukemia.

Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

O. Lortholary, C. Cordonnier, S. Bastuji‐Garin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice

D. Klatzmann, B. Salomon, S. Maury, 1995, Molecular and cellular biology.

De-escalation and discontinuation strategies in high-risk neutropenic patients: an interrupted time series analyses of antimicrobial consumption and impact on outcome

M. Venditti, C. Cordonnier, W. Akrout, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.

B. Salomon, F. Charlotte, Y. Belkacemi, 2016, Blood.

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories.

M. Mohty, J. Mary, G. Socié, 2008, Blood.

Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study

F. Roudot-thoraval, D. Klatzmann, G. Socié, 2014, Leukemia.

Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia

I. Durand-zaleski, H. Esperou, C. Cordonnier, 2005, Bone Marrow Transplantation.

Maury Hematopoietic Stem Cell Transplantation Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Regulatory T Cell Depletion Improves the + CD 25 + CD 4

F. Roudot-thoraval, D. Klatzmann, C. Badoual, 2010 .

CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation

F. Roudot-thoraval, D. Klatzmann, C. Badoual, 2010, Science Translational Medicine.

Searching for factors to improve the antileukemic effect of donor lymphocyte infusion.

D. Klatzmann, C. Cordonnier, J. Cohen, 2008, Blood.

Depletion of T regulatory cells through selection of CD127-positive cells results in a population enriched in memory T cells: implications for anti-tumor cell therapy

D. Landau, D. Klatzmann, M. Rosenzwajg, 2012, Haematologica.

Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

I. Yakoub-Agha, D. Blaise, J. Bay, 2017, Bone Marrow Transplantation.

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia

H. Dombret, F. Lacombe, E. Macintyre, 2010, Haematologica.

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2006 .

Is Less Chemotherapy Detrimental in Adults with Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) Treated with High-Dose Imatinib? Results of the Prospective Randomized Graaph-2005 Study

J. Cayuela, H. Dombret, S. Leprêtre, 2012 .

First Results of the GRAAPH-2005 Study in younger Adult Patients with De Novo Philadelphia Positive Acute Lymphoblastic Leukemia

J. Cayuela, H. Dombret, S. Leprêtre, 2008 .

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients

J. Mary, A. Toubert, M. Carmagnat, 2001, British journal of haematology.

Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host disease.

E. Piaggio, J. Cohen, S. Maury, 2014, Immunology letters.

Ex Vivo-Expanded CD4+CD25+ Immunoregulatory T Cells Prevent Graft-versus-Host-Disease by Inhibiting Activation/Differentiation of Pathogenic T Cells1

D. Klatzmann, B. Salomon, F. Charlotte, 2006, The Journal of Immunology.

Activation / Differentiation of Pathogenic T Graft-versus-Host-Disease by Inhibiting Immunoregulatory T Cells Prevent + CD 25 + Ex Vivo-Expanded CD 4

D. Klatzmann, B. Salomon, F. Charlotte, 2005 .

Generation of Human Alloantigen-Specific Regulatory T Cells under Good Manufacturing Practice-Compliant Conditions for Cell Therapy

Y. Hamel, F. Charlotte, M. Guillot-Delost, 2015, Cell transplantation.

Fusion Gene Detection and Quantification by Asymmetric Capture Sequencing (aCAP-Seq).

J. Cayuela, L. Roy, D. Bories, 2022, The Journal of molecular diagnostics : JMD.

Donor Regulatory T Cells Identified by FoxP3 Expression but Also by the Membranous CD4+CD127low/neg Phenotype Influence Graft-versus-tumor Effect After Donor Lymphocyte Infusion

Y. Hamel, C. Cordonnier, C. Pautas, 2008, Journal of immunotherapy.

Clinical‐grade preparation of human natural regulatory T‐cells encoding the thymidine kinase suicide gene as a safety gene

D. Klatzmann, Y. Hamel, A. Six, 2008, The journal of gene medicine.

Antibody response after second BNT162b2 dose in allogeneic HSCT recipients

S. Fourati, A. Le Bouter, S. Maury, 2021, The Lancet.

TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation

F. Issa, B. Salomon, F. Charlotte, 2022, Journal for ImmunoTherapy of Cancer.

Clinical grade preparation of human natural regulatory T‐cells encoding the thymidine kinase suicide gene as a safety gene: authors' reponse

D. Klatzmann, Y. Hamel, A. Six, 2009, The journal of gene medicine.

Clofarabine as a potential stimulant of alloreactivity

C. Cordonnier, C. Pautas, S. Maury, 2011, Bone Marrow Transplantation.

High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia

H. Dombret, X. Thomas, C. Récher, 2006, Leukemia.

Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry.

A. Nagler, G. Ossenkoppele, M. Boogaerts, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

I11 Epidemiology and risk factors for serious infections in the stem cell transplant setting

C. Cordonnier, S. Maury, 2007 .

Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France

M. Robin, Y. Bertrand, P. Rohrlich, 2019, Haematologica.

Comparison of umbilical cord blood allogeneic stem cell transplantation vs. auto‐SCT for adult acute myeloid leukemia patients in second complete remission at transplant: a retrospective study on behalf of the SFGM‐TC

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2015, European journal of haematology.

Long-Term Results of the Imatinib GRAAPH-2003 Study in Newly-Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

J. Cayuela, H. Dombret, E. Macintyre, 2009 .

Epigenetic Therapy with 5-Azacitidine, Valproic Acid, and ATRA in Patients with High-Risk AML or MDS: Results of the French VIVEDEP Phase II Study

H. Dombret, C. Gardin, C. Récher, 2008 .

Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT

L. Roy, C. Pautas, S. Fourati, 2022, The Lancet Haematology.

Allogeneic stem cell transplantation (allo-SCT) for de novo Ph+ AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy

I. Yakoub-Agha, D. Blaise, M. Mohty, 2015, Bone Marrow Transplantation.

Efficacy of Tyrosine Kinase Inhibitors in Ph-like Acute Lymphoblastic Leukemia harboring ABL-class Rearrangements.

J. Soulier, E. Clappier, H. Dombret, 2019, Blood.

A Grading System Based on Severity of Infection to Predict Mortality in Allogeneic Stem Cell Transplant Recipients

S. Chevret, E. Gluckman, C. Cordonnier, 2006, Transplantation.

Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single‐lineage marrow failure: a pilot study and a survey from the EBMT WPSAA

J. Passweg, A. Tichelli, A. Risitano, 2010, British journal of haematology.

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen

M. Aljurf, J. Passweg, A. Bacigalupo, 2009, Haematologica.

Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.

P. Bierling, H. Ansart‐Pirenne, C. Cordonnier, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease.

H. Volk, I. Anegon, E. Piaggio, 2020, Blood advances.

Dominant immune response to HLA‐B57/B58 molecules after platelet transfusion

F. Pirenne, H. Ansart‐Pirenne, B. Vingert, 2020, Transfusion.

Molecular Demonstration of a Pneumocystis Outbreak in Stem Cell Transplant Patients: Evidence for Transmission in the Daycare Center

C. Cordonnier, F. Botterel, C. Angebault, 2017, Front. Microbiol..

Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study

C. Cordonnier, S. Bastuji‐Garin, F. Botterel, 2011, Haematologica.

Graft-versus-leukemia effect after suicide-gene-mediated control of graft-versus-host disease.

D. Klatzmann, O. Boyer, J. Cohen, 2002, Blood.

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

A. Amiot, E. Sbidian, P. Grimbert, 2022, Scientific Reports.

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2014, Bone Marrow Transplantation.

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor.

C. Cordonnier, C. Hézode, J. Beaumont, 2014, Blood.

Ivosidenib Monotherapy Is Effective in Patients with IDH1 Mutated Myelodysplastic Syndrome (MDS): The Idiome Phase 2 Study By the GFM Group

E. Clappier, S. Chevret, P. Fenaux, 2021, Blood.

Effect of combined cytostatic cyclosporin A and cytolytic suicide gene therapy on the prevention of experimental graft-versus-host disease

D. Klatzmann, Jl Cohen, O. Boyer, 2002, Gene Therapy.

Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC

M. Labopin, M. Robin, P. Chevallier, 2022, Bone Marrow Transplantation.

Third Early “Booster” Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses

J. Pawlotsky, S. Fourati, A. Ahmed-Belkacem, 2022, Viruses.

Plasma concentrations of atovaquone given to immunocompromised patients to prevent Pneumocystis jirovecii

M. Lê, C. Cordonnier, A. Hulin, 2017, The Journal of antimicrobial chemotherapy.

Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice.

D. Klatzmann, B. Salomon, J. Cohen, 2001, Blood.

ANTIPNEUMOCOCCAL SEROPROTECTION YEARS AFTER VACCINATION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS.

C. Cordonnier, C. Pautas, M. Bahuaud, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pneumococcal immunization in immunocompromised hosts: where do we stand?

C. Cordonnier, D. Engelhard, D. Averbuch, 2014, Expert review of vaccines.

Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis.

C. Cordonnier, S. Bastuji‐Garin, F. Botterel, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Treatment with 5-azacytidin upregulates the expression of CD20 in CD20-negative B cell acute lymphoblastic leukemia: a case report.

C. Cordonnier, O. Wagner-Ballon, C. Pautas, 2013, Experimental hematology.

Calcineurin activity as a functional index of immunosuppression after allogeneic stem-cell transplantation1

R. Barouki, C. Cordonnier, C. Pautas, 2004, Transplantation.

New findings and key questions in hematopoietic stem cell transplantation.

C. Cordonnier, F. Botterel, S. Bretagne, 2005, Medical mycology.

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

C. Cordonnier, S. Bretagne, P. Ribaud, 2004, Bone Marrow Transplantation.

Successful non-myeloablative allogeneic HLA-identical stem cell transplantation for CD4/CD56 positive acute leukemia.

H. Jouault, C. Cordonnier, C. Pautas, 2007, Transplantation.

Searching for Factors to Improve Regulatory T Cell Therapy in Organ Transplantation

P. Grimbert, C. Pilon, S. Maury, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Regulatory T‐cell depletion in donor lymphocyte infusions for haematological malignancies: long‐term outcomes from a prospective study

J. Cohen, S. Maury, S. Vigouroux, 2014, British journal of haematology.

Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process?

P. Gaulard, C. Cordonnier, D. Bories, 2011, European journal of haematology.

Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.

D. Landau, D. Klatzmann, G. Bensimon, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia.

J. Bourhis, H. Dombret, S. Chevret, 2020, Blood.

Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.

A. Vekhoff, L. Adès, C. Cordonnier, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Updated guidelines for managing fungal diseases in hematology patients

C. Cordonnier, C. Pautas, S. Maury, 2010, Expert review of anti-infective therapy.

Empirical Versus Pre-Emptive Antifungal Therapy in High-Risk Febrile Neutropenic Patients: A Prospective Randomized Study.

A. Vekhoff, S. Leprêtre, L. Adès, 2006 .

Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model

B. Farley, A. Vekhoff, S. Leprêtre, 2013, PloS one.

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors

S. Fourati, S. Maury, D. Challine, 2021, The Lancet Haematology.

Overcoming the Negative Impact of Age Using Fludarabine-Based Conditioning Regimens for HLA-Identical Sibling HSCT in Patients with Severe Aplastic Anemia (SAA): A Study from the EBMT-SAA Working Party.

D. Blaise, J. Passweg, A. Bacigalupo, 2006 .

A landscape of germ line mutations in a cohort of inherited bone marrow failure patients.

J. Soulier, E. Clappier, A. Baruchel, 2018, Blood.

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.

J. Cayuela, H. Dombret, S. Leprêtre, 2015, Blood.

Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.

J. Bourhis, H. Dombret, P. Chevallier, 2015, Blood.

Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.

H. Dombret, S. Chevret, P. Chevallier, 2016, The New England journal of medicine.

Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia chromosome/BCR-ABL1 positive acute Lymphoblastic Leukemia (ALL): A trial of the European Working Group for Adult ALL (EWALL-PH-02)

N. Schmitz, J. Cayuela, H. Dombret, 2014 .

Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines?

C. Cordonnier, F. Botterel, C. Pautas, 2018, Bone Marrow Transplantation.

M. Bernard, P. Chevallier, I. Yakoub-Agha, 2016, Haematologica.

Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.

S. Chevret, P. Chevallier, I. Yakoub-Agha, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation

H. Dombret, E. Macintyre, S. Leprêtre, 2020, Leukemia.

CHIMERISM ANALYSIS BY LINEAGE-SPECIFIC FLUORESCENT POLYMERASE CHAIN REACTION IN SECONDARY GRAFT FAILURE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

M. Tulliez, H. Jouault, C. Cordonnier, 2001, Transplantation.

Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population

C. Cordonnier, D. Bories, K. Belhadj, 2001, Bone Marrow Transplantation.

Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO‐incompatible allogeneic haematopoietic stem cell transplantation

F. Noizat‐Pirenne, C. Cordonnier, C. Pautas, 2007, Vox sanguinis.

[Vaccination post hematopoietic stem cell transplantation: which vaccines and when and, how to vaccinate? An SFGM-TC report].

I. Yakoub-Agha, O. Reman, F. Suarez, 2013, Pathologie-biologie.

Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation.

J. Kurtzberg, M. Aljurf, J. Passweg, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.

M. Robin, I. Yakoub-Agha, D. Blaise, 2013, Experimental hematology.

Allogeneic hematopoietic stem cell transplantation in the COVID-19 era

S. Maury, M. Leclerc, Jonathan Bordat, 2023, Frontiers in Immunology.

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT

S. Fourati, A. Le Bouter, S. Maury, 2021, The Lancet Haematology.

Le programme JACIE (Joint Accreditation Committee of ISCT-Europe and EBMT). Pourquoi ? Pour qui ?

H. Esperou, C. Cordonnier, C. Pautas, 2008 .

Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy

J. Bourhis, I. Yakoub-Agha, M. Mohty, 2013, Haematologica.

G. Socié, N. Milpied, P. Bordigoni, 2007, Haematologica.

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study

Pierre-Yves Dumas, Dominique Bordessoule, Fabrice Jardin, 2016, American journal of hematology.

Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia

A. Fischer, E. Lanino, I. Yakoub-Agha, 2013, American journal of hematology.

Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

N. Kröger, S. Iacobelli, M. Robin, 2021, Bone Marrow Transplantation.

Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study

J. Bourhis, P. Chevallier, I. Yakoub-Agha, 2020, Bone Marrow Transplantation.

Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation.

C. Picard, P. Chevallier, C. Elie, 2016, The Journal of allergy and clinical immunology.

Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning

M. Aljurf, S. Maury, 2013, Bone Marrow Transplantation.

Applying the concept of healthcare-associated infections to hematology programs.

J. Carlet, P. Legrand, C. Cordonnier, 2006, Haematologica.

Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire

P. Chevallier, M. Mohty, J. Cassuto, 2016, Transplantation.

Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease

M. Abramowicz, V. Flamand, A. Le Moine, 2021, Frontiers in Immunology.

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT

S. Montoto, H. Tilly, C. Crawley, 2013, Bone Marrow Transplantation.

Simple, Reproducible, and Efficient Clinical Grading System for Murine Models of Acute Graft-versus-Host Disease

F. Charlotte, Y. Belkacemi, J. Cohen, 2018, Front. Immunol..

Retrospective Survey on the Prevalence and Outcome of Prior Autoimmune Diseases in Patients with Aplastic Anemia Reported to the Registry of the European Group for Blood and Marrow Transplantation

E. Lanino, A. Wåhlin, J. Passweg, 2010, Acta Haematologica.

graft-versus-host disease mediated control of - Graft-versus-leukemia effect after suicide-gene

O. Boyer, J. Cohen, G. Boisserie, 2013 .

Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients

I. Durand-zaleski, C. Cordonnier, F. Hemery, 2017, BMC Infectious Diseases.

Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

B. Nadel, H. Dombret, E. Macintyre, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Addition of Rituximab Improves the Outcome of Adult Patients with CD20-Positive, Ph-Negative, B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Graall-R 2005 Study

H. Dombret, S. Chevret, P. Chevallier, 2015 .

Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2

F. Pasquier, E. Clappier, H. Dombret, 2021, Blood.

Nilotinib (Tasigna®) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)

J. Cayuela, H. Dombret, K. Spiekermann, 2018, Blood.

Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

J. Bourhis, P. Chevallier, D. Blaise, 2016, Bone Marrow Transplantation.

L-asparaginase for adult CD20 positive B-cell precursor acute lymphoblastic leukemia

H. Dombret, M. Béné, N. Ifrah, 2010, Haematologica.

Isocitrate Dehydrogenase (IDH) 1 and 2 Mutation Is an Independent Predictor of Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Study of the ALWP of EBMT

J. Esteve, A. Ganser, J. Bourhis, 2021, Blood.

LONG-TERM IMMUNITY TO MEASLES AFTER ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION: FACTORS ASSOCIATED WITH SEROPROTECTION BEFORE REVACCINATION: Immunity to measles after HCT.

F. Rozenberg, C. Cordonnier, C. Pautas, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study

J. Bourhis, M. Labopin, I. Yakoub-Agha, 2022, Bone Marrow Transplantation.

Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation

S. Iacobelli, P. Chevallier, P. Dreger, 2019, British journal of haematology.

ABO blood barrier to engraftment after allogeneic stem cell transplantation in sickle cell disease: A case‐story with two successive HLA‐matched sibling donors

P. Bartolucci, S. Maury, I. Sloma, 2022, American journal of hematology.

Hyper-CVAD + epratuzumab as a salvage regimen for younger patients with relapsed/refractory CD22-positive precursor B-cell acute lymphocytic leukemia

H. Dombret, P. Chevallier, M. Béné, 2017, Haematologica.

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

F. Jardin, T. Petrella, E. Macintyre, 2019, Blood advances.

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

M. Robin, D. Blaise, G. Guillerm, 2023, Bone Marrow Transplantation.

Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial.

A. Rosenwald, M. Ziepert, N. Schmitz, 2017 .

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study.

H. Dombret, M. Bernard, P. Chevallier, 2011, Blood.

Risk Factors and Scoring System for Predicting Bacterial Resistance to Cefepime as Used Empirically in Haematology Wards

P. Legrand, C. Cordonnier, C. Pautas, 2015, BioMed research international.

Results of the AFR07 Prospective Study in De Novo Philadelphia Positive ALL Patients Aged over 55 Years: Efficacy and Safety of a Glivec® Based Induction Followed by Maintenance Therapy with Glivec® and Pegasys®.

J. Cayuela, H. Dombret, C. Récher, 2007 .

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study

E. Solary, C. Preudhomme, P. Fenaux, 2020, Leukemia.

Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients

L. Roy, C. Pautas, S. Fourati, 2022, Journal of Hematology & Oncology.

A new workflow for the microbiological diagnosis of febrile neutropenia in patients with a central venous catheter.

E. Sbidian, C. Cordonnier, S. Bastuji‐Garin, 2013, The Journal of antimicrobial chemotherapy.

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

R. Houot, S. Chevret, L. Michel, 2023, The Lancet.

Can a reduced-intensity conditioning regimen cure blastic plasmacytoid dendritic cell neoplasm?

F. Jardin, P. Chevallier, I. Yakoub-Agha, 2017, Blood.

Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administration

C. Cordonnier, S. Bastuji‐Garin, C. Pautas, 2016, American journal of hematology.

Subcutaneous Alemtuzumab Is a Safe and Effective Treatment for Global or Single-Lineage Immune-Mediated Marrow Failures: a Survey from the EBMT-WPSAA

J. Passweg, A. Tichelli, A. Risitano, 2008 .

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL): Results From The Group For Research On Adult ALL (GRAALL)

H. Dombret, P. Chevallier, D. Blaise, 2013 .

Toxoplasmosis as an early complication of allogeneic hematopoietic cell transplantation.

C. Cordonnier, F. Botterel, C. Angebault, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

L. Kanz, A. Nagler, D. Niederwieser, 2006 .

A rationale to prioritise vaccination of HSCT patients against COVID-19

S. Maury, M. Leclerc, 2021, The Lancet Haematology.

Reduced Intensity Versus Myelo-Ablative Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Study of the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

F. Jardin, P. Chevallier, I. Yakoub-Agha, 2015 .

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2007 .

Divergent CD4+ T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients

S. Kerbrat, F. Pirenne, B. Vingert, 2023, Frontiers in immunology.

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2007 .

Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study

R. Houot, S. Chevret, L. Michel, 2023, The Lancet.

Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host disease.

E. Piaggio, J. Cohen, S. Maury, 2014, Immunology letters.

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

J. Cayuela, H. Dombret, E. Macintyre, 2007, Blood.

Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.

H. Dombret, S. Chevret, P. Chevallier, 2016, The New England journal of medicine.

Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.

H. Dombret, S. Leprêtre, P. Chevallier, 2023, Haematologica.

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no‐treatment study

R. Porcher, F. Jardin, M. Mohty, 2016, American journal of hematology.

Human herpesvirus 6 (HHV- 6) associated post-transplant acute limbic encephalitis: A case report

C. Pautas, S. Maury, A. Toma, 2015 .

O. Lortholary, C. Cordonnier, S. Bastuji‐Garin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Updated guidelines for managing fungal diseases in hematology patients

C. Cordonnier, C. Pautas, S. Maury, 2010, Expert review of anti-infective therapy.

Pneumococcal immunization in immunocompromised hosts: where do we stand?

C. Cordonnier, D. Engelhard, D. Averbuch, 2014, Expert review of vaccines.

Frequency and Outcome of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR-ABL1 Clonal Hematopoiesis after Blast Clearance: Results from the Graaph-2014 Trial

J. Soulier, E. Clappier, J. Cayuela, 2021, Blood.

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia

H. Dombret, N. Ifrah, A. Buzyn, 2010, Haematologica.